|Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult …|
American journal of ophthalmology 131 (5), 541-560, 2001
|Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.|
KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ...
Ophthalmology 110 (4), 667-673, 2003
|Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)|
U Schmidt-Erfurth, V Chong, A Loewenstein, M Larsen, E Souied, ...
British Journal of Ophthalmology 98 (9), 1144-1167, 2014
|Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical …|
MS Blumenkranz, NM Bressler, SB Bressler, G Donati, GE Fish, ...
Archives of ophthalmology 120 (10), 1307-14, 2002
|Digital Indocyanine-green Angilography in Chorioretinal Disorders|
DR Guyer, CA Puliafito, JM Monés, E Friedman, W Chang, SR Verdooner
Ophthalmology 99 (2), 287-291, 1992
|Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study|
G Soubrane, A Cruess, A Lotery, D Pauleikhoff, J Monès, X Xu, G Zlateva, ...
Archives of ophthalmology 125 (9), 1249-1254, 2007
|Prevalence of age-related macular degeneration in Europe: the past and the future|
JM Colijn, GHS Buitendijk, E Prokofyeva, D Alves, ML Cachulo, ...
Ophthalmology 124 (12), 1753-1763, 2017
|Treat-and-extend regimens with anti-VEGF agents in retinal diseases: a literature review and consensus recommendations|
KB Freund, JF Korobelnik, R Devenyi, C Framme, J Galic, E Herbert, ...
Retina 35 (8), 1489-1506, 2015
|Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3|
SR Sadda, R Guymer, FG Holz, S Schmitz-Valckenberg, CA Curcio, ...
Ophthalmology 125 (4), 537-548, 2018
|Management of retinal vein occlusion–consensus document|
G Coscas, A Loewenstein, A Augustin, F Bandello, MB Parodi, P Lanzetta, ...
Ophthalmologica 226 (1), 4-28, 2011
|Economic burden of bilateral Neovascular age-related macular degeneration|
AF Cruess, G Zlateva, X Xu, G Soubrane, D Pauleikhoff, A Lotery, ...
Pharmacoeconomics 26 (1), 57-73, 2008
|Treat-and-extend versus monthly regimen in neovascular age-related macular degeneration: results with ranibizumab from the TREND study|
R Silva, A Berta, M Larsen, W Macfadden, C Feller, J Monés, ...
Ophthalmology 125 (1), 57-65, 2018
|Evolving European guidance on the medical management of neovascular age related macular degeneration|
U Chakravarthy, G Soubrane, F Bandello, V Chong, C Creuzot-Garcher, ...
British Journal of Ophthalmology 90 (9), 1188-1196, 2006
|Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from classification of atrophy consensus meetings|
FG Holz, SVR Sadda, G Staurenghi, M Lindner, AC Bird, BA Blodi, ...
Ophthalmology 124 (4), 464-478, 2017
|Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results|
JM Mones, L Amselem, A Serrano, M Garcia, M Hijano
Eye 23 (6), 1275-1281, 2009
|Retinal vein occlusions|
J Jonas, M Paques, J Monés, A Glacet-Bernard
Macular edema 47, 111-135, 2010
|Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration|
J Mones, GS Rubin
Eye 19 (11), 1142-1150, 2005
|Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials …|
M Azab, M Benchaboune, KJ Blinder, NM Bressler, SB Bressler, ...
Retina (Philadelphia, Pa.) 24 (1), 1-12, 2004
|Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study|
M Larsen, SM Waldstein, F Boscia, H Gerding, J Monés, R Tadayoni, ...
Ophthalmology 123 (5), 1101-1111, 2016
|Individualized Stabilization Criteria–Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER|
R Tadayoni, SM Waldstein, F Boscia, H Gerding, I Pearce, S Priglinger, ...
Ophthalmology 123 (6), 1332-1344, 2016